Ji Xiang An
Chairman chez Changchun BCHT Pharmaceuticals Co. Ltd.
Profil
Ji Xiang An is currently the Chairman at Changchun BCHT Pharmaceuticals Co. Ltd., Director at Jilin Huakang Pharmaceutical Co. Ltd., Director at GeneScience Pharmaceuticals Co., Ltd., and Director at Changchun Baiyi Pharmaceutical Co., Ltd.
Previously, he served as the Chairman at Changchun BCHT Biotechnology Co. from 2004 to 2021 and as the General Manager & Director at Changchun High & New Technology Industries (Group), Inc. from 2018 to 2021.
Postes actifs de Ji Xiang An
Sociétés | Poste | Début |
---|---|---|
GeneScience Pharmaceuticals Co., Ltd.
GeneScience Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology GeneScience Pharmaceuticals Co., Ltd. engages in the production and sale of biopharmaceutical products. Its products include bioengineering products such as recombinant human growth hormones, active pharmaceutical ingredients such as tripplein acetate and alprostadil, freeze-dried powder injections, small volume injections, biological product intermediates, and medical devices. The company was founded by Lei Jin in 1996 and is headquartered in Changchun, China. | Director/Board Member | 18/03/2014 |
Changchun BCHT Pharmaceuticals Co. Ltd. | Chairman | 22/01/2013 |
Jilin Huakang Pharmaceutical Co. Ltd.
Jilin Huakang Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Changchun High & New Technology Industries (Group), Inc., Jilin Huakang Pharmaceutical Co. Ltd. is a Chinese pharmaceutical company that manufactures pharmaceutical products. The private company is based in Dunhua, China. | Director/Board Member | 12/03/2014 |
Changchun Baiyi Pharmaceutical Co., Ltd.
Changchun Baiyi Pharmaceutical Co., Ltd. Medical SpecialtiesHealth Technology Part of Changchun High-Tech Industry (Group) Co., Ltd., Changchun Baiyi Pharmaceutical Co., Ltd. is a private company that manufactures biological pharmaceutical products. Changchun Baiyi Pharmaceutical Co., Ltd. is based in Changchun, China. Changchun Baiyi Pharmaceutical Co. was acquired by Changchun BCHT Biotechnology Co. on June 14, 2013 for $1.67 million. | Director/Board Member | 01/08/2013 |
Anciens postes connus de Ji Xiang An
Sociétés | Poste | Fin |
---|---|---|
CHANGCHUN BCHT BIOTECHNOLOGY CO. | Chairman | 09/07/2021 |
CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. | Chief Executive Officer | 23/06/2021 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. | Health Technology |
CHANGCHUN BCHT BIOTECHNOLOGY CO. | Health Technology |
Entreprise privées | 4 |
---|---|
Jilin Huakang Pharmaceutical Co. Ltd.
Jilin Huakang Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Changchun High & New Technology Industries (Group), Inc., Jilin Huakang Pharmaceutical Co. Ltd. is a Chinese pharmaceutical company that manufactures pharmaceutical products. The private company is based in Dunhua, China. | Health Technology |
GeneScience Pharmaceuticals Co., Ltd.
GeneScience Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology GeneScience Pharmaceuticals Co., Ltd. engages in the production and sale of biopharmaceutical products. Its products include bioengineering products such as recombinant human growth hormones, active pharmaceutical ingredients such as tripplein acetate and alprostadil, freeze-dried powder injections, small volume injections, biological product intermediates, and medical devices. The company was founded by Lei Jin in 1996 and is headquartered in Changchun, China. | Health Technology |
Changchun BCHT Pharmaceuticals Co. Ltd. | |
Changchun Baiyi Pharmaceutical Co., Ltd.
Changchun Baiyi Pharmaceutical Co., Ltd. Medical SpecialtiesHealth Technology Part of Changchun High-Tech Industry (Group) Co., Ltd., Changchun Baiyi Pharmaceutical Co., Ltd. is a private company that manufactures biological pharmaceutical products. Changchun Baiyi Pharmaceutical Co., Ltd. is based in Changchun, China. Changchun Baiyi Pharmaceutical Co. was acquired by Changchun BCHT Biotechnology Co. on June 14, 2013 for $1.67 million. | Health Technology |